Clinical trial
Autologous Transplantation After a Rituximab/Ibrutinib/Ara-c Containing iNduction in Generalized Mantle Cell Lymphoma - a Randomized European Mcl Network Trial
The primary objective of the the trial is to establish one of three study arms, as future standard based on the comparison of the investigator-assessed failure-free survival.
| Category | Value |
|---|---|
| Date last updated at source | 2016-03-06 |
| Study type(s) | Interventional |
| Expected enrolment | 870 |
| Study start date | 2016-07-01 |
| Estimated primary completion date | 2021-05-01 |